Literature DB >> 8561198

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

M S Buchsbaum1, T Someya, C Y Teng, L Abel, S Chin, A Najafi, R J Haier, J Wu, W E Bunney.   

Abstract

OBJECTIVE: This study reports the first paired measurements of glucose metabolism and size of thalamic regions in never-medicated schizophrenic patients using coregistered magnetic resonance imaging (MRI) templates.
METHOD: Positron emission tomography with [18F]fluorodeoxyglucose and matching MRI scans were obtained in 20 never-medicated patients with schizophrenia and 15 normal volunteers. Methods for thalamic edge finding, statistical testing of shape differences with chi-square maps, and MRI localization of major thalamic subregions were developed.
RESULTS: Patients with schizophrenia showed a diminished metabolic rate in the right thalamus, with a loss of the normal pattern of right greater than left asymmetry. Division into anterior/posterior segments revealed that the left anterior and right posterior showed the decrease. Differences were greater for metabolism in the weighted thalamic area (ratexarea) than for rate per unit area, a finding consistent with reported greater decreases in total neuron number than of neuron density in the thalami of schizophrenic patients. The area of the thalamus was smaller in the patients than in the volunteers, and this difference was greatest in the left anterior region.
CONCLUSIONS: The reduced thalamic activity observed in this study lends further support to the concept of deficits in sensory filtering in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8561198     DOI: 10.1176/ajp.153.2.191

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  47 in total

1.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics.

Authors:  G J Popken; W E Bunney; S G Potkin; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 2.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

Review 3.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

4.  Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia.

Authors:  Vicente Molina; Javier Sanz; Fernando Sarramea; Rogelio Luque; Carlos Benito; Tomás Palomo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-09-14       Impact factor: 5.270

5.  Interhemispheric asymmetry of brain diffusivity in normal individuals: a diffusion-weighted MR imaging study.

Authors:  Andrew J Fabiano; Mark A Horsfield; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

6.  The primate thalamus is a key target for brain dopamine.

Authors:  Miguel Angel Sánchez-González; Miguel Angel García-Cabezas; Beatriz Rico; Carmen Cavada
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

7.  Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study.

Authors:  J D Ragland; R C Gur; J Raz; L Schroeder; C G Kohler; R J Smith; A Alavi; R E Gur
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

8.  Dissociable interference-control processes in perception and memory.

Authors:  Derek Evan Nee; John Jonides
Journal:  Psychol Sci       Date:  2008-05

Review 9.  The Gordon Wilson Lecture. Decade of the brain: advances and hopes at the midpoint.

Authors:  G S Oxford
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

10.  Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia.

Authors:  Robert C Welsh; Ashley C Chen; Stephan F Taylor
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.